Invesco Ltd. Acquires 16,717 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Invesco Ltd. grew its position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 6.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 258,520 shares of the company's stock after buying an additional 16,717 shares during the quarter. Invesco Ltd. owned approximately 0.46% of Astrana Health worth $8,151,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. Handelsbanken Fonder AB lifted its position in shares of Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after purchasing an additional 400 shares in the last quarter. Swiss National Bank raised its position in Astrana Health by 1.1% during the fourth quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after acquiring an additional 1,000 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of Astrana Health by 19.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after purchasing an additional 1,184 shares during the period. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Astrana Health in the fourth quarter valued at approximately $40,000. Finally, Pictet Asset Management Holding SA raised its position in shares of Astrana Health by 21.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after purchasing an additional 1,273 shares during the period. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Price Performance

Shares of NASDAQ ASTH traded down $0.50 during mid-day trading on Tuesday, hitting $30.24. 8,777 shares of the stock were exchanged, compared to its average volume of 276,554. The company has a market cap of $1.52 billion, a P/E ratio of 23.23, a PEG ratio of 1.37 and a beta of 1.04. The stock's fifty day simple moving average is $31.01 and its two-hundred day simple moving average is $37.87. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health, Inc. has a twelve month low of $23.12 and a twelve month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). The firm had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. As a group, analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Analysts Set New Price Targets

ASTH has been the subject of a number of research reports. Bank of America reduced their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Stifel Nicolaus cut their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Truist Financial cut their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research report on Tuesday, March 18th. Finally, Barclays started coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective for the company. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.